Sesamum indicum diet prevents hyperlipidemia in experimental rats

Cardiovascular diseases and metabolic complications caused by hyperlipidemia are the leading cause of death globally. In this study, the hypolipidemic potency of Sesamum indicum (SI) seeds was investigated. Of the thirty-five (35) male rats used in the study, five (5) were randomly selected for baseline measurements and thirty (30) were fed high fat diet (HFD) for four (4) weeks before random assignment into three (3) groups. The experimental group was treated with 50% SI seed, the positive control group was given a hypolipidemic drug, atorvastatin (5 mg/kg/day) while the untreated group served as the negative control. With SI administration, the dyslipidemia induced by the HFD consumption in the plasma and the investigated body organs was reversed to a comparable degree with that of atorvastatin treatment. Taken together, this study demonstrates the hypolipidemic potency of SI in ameliorating hyperlipidemia and its associated complications, facilitated by the inhibition of HMG-CoA reductase activity

Insights into the microbial composition and potential efficiency of selected commercial biofertilisers

This study investigated 13-commercial biofertilisers for their microbial contents and potential functional capabilities using a culture-based approach. Isolates obtained were identified by sequencing the partial I6S rRNA gene and ITS 1 and 2 regions and screened for plant growth-promoting capabilities. A total of 58 bacterial and three fungal isolates were obtained from all biofertilisers, with major genera being Bacillus, Rhizobium, Pseudomonas, Candida and Aspergillus. Five of the biofertilisers had the microbes (all or some) listed in the label detected while eight products had none detected. All the products had more microbes than that declared in the labels, suggesting the presence of potential contaminants. Generally, all the identified microbes, including the potential contaminants, had different beneficial capabilities. Approximately 40% of the isolates showed potential for nitrogen-fixation, while 27% exhibited high phosphate-solubilisation ability. Additionally, 87% of the isolates produced indole acetic acid in the range of 0.1–114.4 μg/mL. High levels of siderophore production were mainly observed amongst Bacillus and Pseudomonas genera. The potential of the microbes, including those not listed in the label, to fix nitrogen and produce acid phosphatase, indole acetic acid and siderophore, was highest in four products. This suggests the products have multiple functional abilities in improving crop productivity. However, other qualities of biofertiliser, such as viable cell count and level of contamination, must always be within the acceptable standards. This will guarantee high product quality as well as efficiency when applied in the field. Overall, the results show that there is a high correlation between microbial compositions and potential capability of biofertilisers for plant-growth promotio

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population